# A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC

> **NCT03546452** · — · UNKNOWN · sponsor: **Shanghai Chest Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Malignant Hydrothorax
- NSCLC

## Interventions

- **DIAGNOSTIC_TEST:** in vitro NGS-panel

## Key facts

- **NCT ID:** NCT03546452
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-18
- **Primary completion:** 2018-09-30
- **Final completion:** 2019-05-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-06-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03546452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03546452, "A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03546452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*